Merck Resumes Xirallic Production in Japan

Merck KGaA resumed normal operations at the Onahama production site in Japan on May 8. Among other products, the Onahama site manufactures Xirallic effect pigments, which are widely used in high-quality automotive coatings by companies such as Chrysler Group, Toyota Motor, General Motors and Ford Motor.

The damage to the production units and infrastructure caused by the catastrophic earth­quake in northeastern Japan on March 11 resulted in the stoppage of pigment production in Onahama. The recovery and repair work, which began on April 4, has been completed ahead of schedule. Merck said it expects the plant will achieve its regular production output in June.

The Onahama site (southern part of Iwaki City) is located 57 km south of the damaged Fukushima Daiichi nuclear power plant, and outside the evacuation zone. Merck is continually monitoring all public directives regarding radiation levels in order to ensure the safety of its employees. The company is also testing the products being shipped from Merck Japan to ensure that they comply fully with all regulations and safety standards.

Apart from Onahama, Merck will establish an alternative production site for Xirallic effect pigments. It is planned to have additional capacity for Xirallic pigments in Germany by the end of 2011. This will considerably boost future supply reliability of Xirallic products as of 2012.

Company

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

Company contact







CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.